Biomanufacturing Excellence Act of 2025

Key Points

• This bill would create a National Biopharmaceutical Center of Excellence to help American companies turn lab discoveries into mass-produced medicines. The goal is to provide the expensive equipment and space needed to prove that new treatments can be made safely and efficiently on a large scale.
• By investing in local manufacturing, the policy aims to make the United States less dependent on foreign countries for its medicine supply. This is seen as a way to protect national health and security by ensuring critical drugs are made right here at home.
• The plan includes $120 million in funding for the 2026 budget year. This money would go toward building new facilities, conducting research on how to make drugs faster, and creating training programs to help workers learn the skills needed for high-tech biotech jobs.

Impact Analysis

Govbase has not yet run an impact analysis on this legislation.